Value of MitraClip in Reducing Functional Mitral Regurgitation

Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular dysfunction have a poor prognosis, with high rates of rehospitalization and mortality. Percutaneous mitral valve repair using the MitraClip (Abbott) has been shown to be safe and effective in secondary...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mehmet Ali Elbey, Luis Augusto Palma Dallan, Guilherme Ferragut Attizzani
Formato: article
Lenguaje:EN
Publicado: Radcliffe Medical Media 2019
Materias:
Acceso en línea:https://doaj.org/article/db305a8918cc49cbba15fc712de1be2b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:db305a8918cc49cbba15fc712de1be2b
record_format dspace
spelling oai:doaj.org-article:db305a8918cc49cbba15fc712de1be2b2021-12-04T16:01:06ZValue of MitraClip in Reducing Functional Mitral Regurgitation10.15420/usc.2018.19.11758-390X1758-3896https://doaj.org/article/db305a8918cc49cbba15fc712de1be2b2019-01-01T00:00:00Zhttps://www.uscjournal.com/articleindex/usc.2018.19.1https://doaj.org/toc/1758-3896https://doaj.org/toc/1758-390XPatients with heart failure who have secondary severe mitral regurgitation due to left ventricular dysfunction have a poor prognosis, with high rates of rehospitalization and mortality. Percutaneous mitral valve repair using the MitraClip (Abbott) has been shown to be safe and effective in secondary severe mitral regurgitation with heart failure. The number of MitraClip procedures performed has increased significantly, as recently published large, randomized clinical studies have shown. However, these studies have drawn different conclusions. This review aims to summarize the current evidence for the MitraClip procedure and provide information for its safe and successful implementation, comparing the studies that examined the use of MitraClip versus medical therapy alone or surgical repair for severe secondary mitral regurgitation.Mehmet Ali ElbeyLuis Augusto Palma DallanGuilherme Ferragut AttizzaniRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENUS Cardiology Review , Vol 13, Iss 1, Pp 30-34 (2019)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Diseases of the circulatory (Cardiovascular) system
RC666-701
Mehmet Ali Elbey
Luis Augusto Palma Dallan
Guilherme Ferragut Attizzani
Value of MitraClip in Reducing Functional Mitral Regurgitation
description Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular dysfunction have a poor prognosis, with high rates of rehospitalization and mortality. Percutaneous mitral valve repair using the MitraClip (Abbott) has been shown to be safe and effective in secondary severe mitral regurgitation with heart failure. The number of MitraClip procedures performed has increased significantly, as recently published large, randomized clinical studies have shown. However, these studies have drawn different conclusions. This review aims to summarize the current evidence for the MitraClip procedure and provide information for its safe and successful implementation, comparing the studies that examined the use of MitraClip versus medical therapy alone or surgical repair for severe secondary mitral regurgitation.
format article
author Mehmet Ali Elbey
Luis Augusto Palma Dallan
Guilherme Ferragut Attizzani
author_facet Mehmet Ali Elbey
Luis Augusto Palma Dallan
Guilherme Ferragut Attizzani
author_sort Mehmet Ali Elbey
title Value of MitraClip in Reducing Functional Mitral Regurgitation
title_short Value of MitraClip in Reducing Functional Mitral Regurgitation
title_full Value of MitraClip in Reducing Functional Mitral Regurgitation
title_fullStr Value of MitraClip in Reducing Functional Mitral Regurgitation
title_full_unstemmed Value of MitraClip in Reducing Functional Mitral Regurgitation
title_sort value of mitraclip in reducing functional mitral regurgitation
publisher Radcliffe Medical Media
publishDate 2019
url https://doaj.org/article/db305a8918cc49cbba15fc712de1be2b
work_keys_str_mv AT mehmetalielbey valueofmitraclipinreducingfunctionalmitralregurgitation
AT luisaugustopalmadallan valueofmitraclipinreducingfunctionalmitralregurgitation
AT guilhermeferragutattizzani valueofmitraclipinreducingfunctionalmitralregurgitation
_version_ 1718372823148265472